{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:32:14Z","timestamp":1791221534975,"version":"4.1.0"},"reference-count":51,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2011,12,26]],"date-time":"2011-12-26T00:00:00Z","timestamp":1324857600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["opencardiovascularmedicinejournal.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["TOCMJ"],"published-print":{"date-parts":[[2011,12,26]]},"abstract":"<jats:p>Obstructive Sleep Apnoea (OSA) is a common disorder in adults. Its hallmark is repetitive episodes of partial or complete obstruction of the upper airway during sleep associated with increasing respiratory efforts. This leads to oxyhaemoglobin desaturation, sleep fragmentation, and daytime symptoms, mainly excessive sleepiness. Accumulating\nevidence suggests that intermittent hypoxia and oxyhaemoglobin desaturation may, irrespective of obesity, lead to elevation of serum lipids even in non-dyslipidaemic OSA patients. Continuous Positive Airway Pressure (CPAP) is the treatment of choice for OSA, since it eliminates upper airway collapse during sleep and improves sleep fragmentation, daytime symptoms and quality of life. Moreover, it has been proposed that the amelioration of breathing disturbances during\nsleep can improve several markers of the lipid profile, such as total cholesterol, triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol as well as apolipoproteins A, B and C. Indeed, some studies have reported improvements in these parameters especially in CPAP adherent patients. However, other studies failed to confirm this beneficial effect. The present article reviews the issue whether CPAP treatment exerts a beneficial effect on lipids.<\/jats:p>","DOI":"10.2174\/1874192401105010231","type":"journal-article","created":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T04:35:57Z","timestamp":1325565357000},"page":"231-238","update-policy":"https:\/\/doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Continuous Positive Airway Pressure Treatment: Effect on Serum Lipids in Patients with Obstructive Sleep Apnoea"],"prefix":"10.2174","volume":"5","author":[{"given":"Vassileios","family":"Michailidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis","family":"Steiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Nena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Papanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efstratios","family":"Maltezos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demosthenes","family":"Bouros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"refR1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1513\/pats.200709-155MG","volume":"5","author":"Punjabi NM","year":"2008","unstructured":"Punjabi NM. \n                    The epidemiology of adult obstructive sleep apnea \n                    Proc Am Thorac Soc  \n                    2008; \n                    5\n                    : 136-43.","journal-title":"Proc Am Thorac Soc"},{"key":"refR2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1183\/09031936.00027406","volume":"29","author":"McNicholas WT","year":"2007","unstructured":"McNicholas WT, Bonsignore MR. \n                    Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, \nbasic mechanisms and research priorities \n                    Eur Respir J  \n                    2007; \n                    29\n                    : 156-78.","journal-title":"Eur Respir J"},{"key":"refR3","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/00063198-200011000-00005","volume":"6","author":"Malhotra A","year":"2000","unstructured":"Malhotra A, Ayas NT, Epstein LJ. \n                    The art and science of \ncontinuous positive airway pressure therapy in obstructive sleep apnea \n                    Curr Opin Pulm Med  \n                    2000; \n                    6\n                    : 490-5.","journal-title":"Curr Opin Pulm Med"},{"key":"refR4","first-page":"CD001106","volume":"3","author":"Giles TL","year":"2006","unstructured":"Giles TL, Lasserson TJ, Smith BH, White J, Wright J, Cates  \nCJ. \n                    Continuous positive airways pressure for obstructive \nsleep apnoea in adults \n                    Cochrane Database Syst Rev  \n                    2006; \n                    3\n                    : CD001106.","journal-title":"Cochrane Database Syst Rev"},{"key":"refR5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.2003.007195","volume":"60","author":"Gordon P","year":"2005","unstructured":"Gordon P, Sanders MH. \n                    Sleep.7: positive airway pressure therapy for obstructive sleep apnoea\/hypopnoea syndrome \n                     Thorax  \n                    2005; \n                    60\n                    : 68-75.","journal-title":"Thorax"},{"key":"refR6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1378\/chest.07-0074","volume":"132","author":"Steiropoulos P","year":"2007","unstructured":"Steiropoulos P, Tsara V, Nena E, et al. \n                    Effect of continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome \n                    Chest  \n                    2007; \n                    132\n                    : 843-51.","journal-title":"Chest"},{"key":"refR7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/sleep\/32.4.537","volume":"32","author":"Steiropoulos P","year":"2009","unstructured":"Steiropoulos P, Kotsianidis I, Nena E, et al. \n                    Long-term effect of continuous positive airway pressure therapy on inflammation markers of patients with obstructive sleep apnea syndrome \n                    Sleep  \n                    2009; \n                    32\n                    : 537-43.","journal-title":"Sleep"},{"key":"refR8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/sleep\/20.4.278","volume":"20","author":"Weaver TE","year":"1997","unstructured":"Weaver TE, Kribbs NB, Pack AI, et al. \n                    Night-to-night variability in CPAP use over the first three months of treatment \n                    Sleep  \n                    1997; \n                    20\n                    : 278-83.","journal-title":"Sleep"},{"key":"refR9","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1378\/chest.130.6.1772","volume":"130","author":"Zimmerman ME","year":"2006","unstructured":"Zimmerman ME, Arnedt JT, Stanchina M, Millman RP, Aloia MS. \n                    Normalization of memory performance and positive airway pressure adherence in memory-impaired patients with obstructive sleep apnea \n                    Chest  \n                    2006; \n                    130\n                    : 1772-8.","journal-title":"Chest"},{"key":"refR10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1183\/09031936.95.08020222","volume":"8","author":"Hedner J","year":"1995","unstructured":"Hedner J, Darpo B, Ejnell H, Carlson J, Caidahl K. \n                    Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications \n                    Eur Respir J  \n                    1995; \n                    8\n                    : 222-9.","journal-title":"Eur Respir J"},{"key":"refR11","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(98)10532-9","volume":"353","author":"Jenkinson C","year":"1999","unstructured":"Jenkinson C, Davies RJ, Mullins R, Stradling JR. \n                    Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial \n                    Lancet  \n                    1999; \n                    353\n                    : 2100-5.","journal-title":"Lancet"},{"key":"refR12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ecl.2008.11.010","volume":"38","author":"Katcher HI","year":"2009","unstructured":"Katcher HI, Hill AM, Lanford JL, Yoo JS, Kris-Etherton PM. \n                    Lifestyle approaches and dietary strategies to lower LDL-cholesterol and triglycerides and raise HDL-cholesterol \n                    Endocrinol Metab Clin North Am  \n                    2009; \n                    38\n                    : 45-78.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"refR13","first-page":"2","volume":"2","author":"Leren P","year":"1980","unstructured":"Leren P, Foss PO, Helgeland A, Hjermann I, Holme I, Lund-Larsen PG. \n                    Effect of propranolol and prazosin on blood lipids \n                    The Oslo Study Lancet  \n                    1980; \n                    2\n                    : 2-4.","journal-title":"The Oslo Study. Lancet"},{"key":"refR14","doi-asserted-by":"crossref","first-page":"21A","DOI":"10.1016\/0002-9149(84)90830-0","volume":"53","author":"Lowenstein J","year":"1984","unstructured":"Lowenstein J. \n                    Effects of prazosi n on serum lipids in patients with essential hypertension: a review of the findings presented at the Satellite Symposium on coronary heart disease, hypertension and other risk factors, Milan \n                    Am J Cardiol  \n                    1984; \n                    53\n                    : 21A-3A.","journal-title":"Am J Cardiol"},{"key":"refR15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1183\/09031936.00166808","volume":"34","author":"L\u00e9vy P","year":"2009","unstructured":"L\u00e9vy P, Bonsignore MR, Eckel J. \n                    Sleep, sleep-disordered breathing and metabolic consequences \n                    Eur Respir J  \n                    2009; \n                    34\n                    : 243-60.","journal-title":"Eur Respir J"},{"key":"refR16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/01.RES.0000183879.60089.a9","volume":"97","author":"Li J","year":"2005","unstructured":"Li J, Thorne LN, Punjabi NM, et al. \n                    Intermittent hypoxia induces hyperlipidemia in lean mice \n                    Circ Res  \n                    2005; \n                    97\n                    : 698-706.","journal-title":"Circ Res"},{"key":"refR17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1152\/japplphysiol.01081.2006","volume":"102","author":"Li J","year":"2007","unstructured":"Li J, Savransky V, Nanayakkara A, Smith PL, O\u2019Donnell CP, Polotsky VY. \n                    Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia \n                    J Appl Physiol  \n                    2007; \n                    102\n                    : 557-63.","journal-title":"J Appl Physiol"},{"key":"refR18","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1152\/japplphysiol.00522.2005","volume":"99","author":"Li J","year":"2005","unstructured":"Li J, Grigoryev DN, Ye SQ, et al. \n                    Chronic intermittent hypoxia upregulates genes of lipid biosynthesis in obese mice \n                    J Appl Physiol  \n                    2005; \n                    99\n                    : 1643-8.","journal-title":"J Appl Physiol"},{"key":"refR19","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.06-1807","volume":"131","author":"Kono M","year":"2007","unstructured":"Kono M, Tatsumi K, Saibara T, et al. \n                    Obstructive sleep apnea syndrome is associated with some components of metabolic \nsyndrome \n                    Chest  \n                    2007; \n                    131\n                    : 1387-92.","journal-title":"Chest"},{"key":"refR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1183\/09031936.06.00131304","volume":"27","author":"B\u00f6rgel J","year":"2006","unstructured":"B\u00f6rgel J, Sanner BM, Bittlinsky A, et al. \n                    Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels \n                    Eur Respir J  \n                    2006; \n                    27\n                    : 121-7.","journal-title":"Eur Respir J"},{"key":"refR21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.129.2.233","volume":"129","author":"Can M","year":"2006","unstructured":"Can M, A\u00e7ikg\u00f6z S, Mungan G, et al. \n                    Serum cardiovascular risk factors in obstructive sleep apnea \n                    Chest  \n                    2006; \n                    129\n                    : 233-7.","journal-title":"Chest"},{"key":"refR22","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1253\/circj.71.1293","volume":"71","author":"Iesato K","year":"2007","unstructured":"Iesato K, Tatsumi K, Saibara T, et al. \n                    Decreased lipoprotein lipase in obstructive sleep apnea syndrome \n                    Circ J  \n                    2007; \n                    71\n                    : 1293-8.","journal-title":"Circ J"},{"key":"refR23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.atherosclerosis.2005.04.024","volume":"184","author":"Tan KC","year":"2006","unstructured":"Tan KC, Chow WS, Lam JC, et al. \n                    HDL dysfunction in obstructive sleep apnea \n                    Atherosclerosis  \n                    2006; \n                    184\n                    : 377-82.","journal-title":"Atherosclerosis"},{"key":"refR24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/aje\/154.1.50","volume":"154","author":"Newman AB","year":"2001","unstructured":"Newman AB, Nieto FJ, Guidry U, et al. \n                    Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study \n                    Am J Epidemiol  \n                    2001; \n                    154\n                    : 50-9.","journal-title":"Am J Epidemiol"},{"key":"refR25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1475-2840-5-22","volume":"5","author":"Gruber A","year":"2006","unstructured":"Gruber A, Horwood F, Sithole J, Ali NJ, Idris I. \n                    Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state \n                    Cardiovasc Diabetol  \n                    2006; \n                    5\n                    : 22.","journal-title":"Cardiovasc Diabetol"},{"key":"refR26","first-page":"238","volume":"68","author":"Zgierska A","year":"2000","unstructured":"Zgierska A, G\u00f3recka D, Radzikowska M, et al. \n                    Obstructive sleep apnea and risk factors for coronary artery disease \n                    Pneumonol Alergol Pol  \n                    2000; \n                    68\n                    : 238-46.","journal-title":"Pneumonol Alergol Pol"},{"key":"refR27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ehj.2004.02.021","volume":"25","author":"Coughlin SR","year":"2004","unstructured":"Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP. \n                    Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome \n                    Eur Heart J  \n                    2004; \n                    25\n                    : 735-41.","journal-title":"Eur Heart J"},{"key":"refR28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1034\/j.1399-3003.2000.16a23.x","volume":"16","author":"Kiely JL","year":"2000","unstructured":"Kiely JL, McNicholas WT. \n                    Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome \n                    Eur Respir J  \n                    2000; \n                    16\n                    :  \n128-33.","journal-title":"Eur Respir J"},{"key":"refR29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.118.3.580","volume":"118","author":"Ip MS","year":"2000","unstructured":"Ip MS, Lam KS, Ho C, Tsang KW, Lam W. \n                    Serum leptin and vascular risk factors in obstructive sleep apnea \n                    Chest  \n                    2000; \n                    118\n                    : 580-6.","journal-title":"Chest"},{"key":"refR30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1164\/rccm.200602-270OC","volume":"175","author":"McArdle N","year":"2007","unstructured":"McArdle N, Hillman D, Beilin L, Watts G. \n                    Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study \n                    Am J Respir Crit Care Med  \n                    2007; \n                    175\n                    : 190-5.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.sleep.2006.06.014","volume":"8","author":"Sharma SK","year":"2007","unstructured":"Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L, Chaturvedi P. \n                    Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing \n                    Sleep Med  \n                    2007; \n                    8\n                    : 12-7.","journal-title":"Sleep Med"},{"key":"refR32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.CIR.100.7.706","volume":"100","author":"Chin K","year":"1999","unstructured":"Chin K, Shimizu K, Nakamura T, et al. \n                    Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy \n                    Circulation  \n                    1999; \n                    100\n                    : 706-12.","journal-title":"Circulation"},{"key":"refR33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1439-054X.2001.01159.x","volume":"5","author":"Buechner NJ","year":"2001","unstructured":"Buechner NJ, Zidek W, Eer M,  Haske M, Sanner BM. \n                    Obstructive sleep apnea syndrome.Effects of therapy on dyslipidemia \n                     Somnologie  \n                    2001; \n                    5\n                    : 97-102.","journal-title":"Somnologie"},{"key":"refR34","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/thx.2003.018739","volume":"59","author":"Robinson GV","year":"2004","unstructured":"Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR. \n                    Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials \n                    Thorax  \n                    2004; \n                    59\n                    : 777-82.","journal-title":"Thorax"},{"key":"refR35","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1378\/chest.08-0556","volume":"134","author":"Dorkova Z","year":"2008","unstructured":"Dorkova Z, Petrasova D, Molcanyiova A, Popovnakova M, Tkacova R. \n                    Effects of continuous positive airway pressure on cardiovascular risk profile in patients with severe obstructive sleep apnea and metabolic syndrome \n                    Chest  \n                    2008; \n                    134\n                    : 686-92.","journal-title":"Chest"},{"key":"refR36","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1136\/thx.2007.093740","volume":"63","author":"Barcel\u00f3 A","year":"2008","unstructured":"Barcel\u00f3 A, Barb\u00e9 F, de la Pe\u00f1a M, et al. \n                    Insulin resistance and \ndaytime sleepiness in patients with sleep apnoea \n                    Thorax  \n                    2008; \n                    63\n                    : 946-50.","journal-title":"Thorax"},{"key":"refR37","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1179\/acb.2009.051","volume":"64","author":"Oktay B","year":"2009","unstructured":"Oktay B, Akbal E, Firat H, Ardi\u00e7 S, Kizilgun M. \n                    CPAP treatment in the coexistence of obstructive sleep apnea syndrome and metabolic syndrome, results of one year follow up \n                    Acta Clin Belg  \n                    2009; \n                    64\n                    : 329-4.","journal-title":"Acta Clin Belg"},{"key":"refR38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00408-008-9131-5","volume":"187","author":"Cuhadaroglu C","year":"2009","unstructured":"Cuhadaroglu C, Utkusavas A, Ozturk L, Salman S, Ece T. \n                    Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea \n                    Lung  \n                    2009; \n                    187\n                    : 75-81.","journal-title":"Lung"},{"key":"refR39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2869.1994.tb00126.x","volume":"3","author":"Davies RJ","year":"1994","unstructured":"Davies RJ, Turner R, Crosby J, Stradling JR. \n                    Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring, their comparison with matched controls and response to treatment \n                    J Sleep Res  \n                    1994; \n                    3\n                    : 180-5.","journal-title":"J Sleep Res"},{"key":"refR40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.amjmed.2004.01.025","volume":"117","author":"Barcel\u00f3 A","year":"2004","unstructured":"Barcel\u00f3 A, Barb\u00e9 F, Llompart E, et al. \n                    Effects of obesity on C-reactive protein level and metabolic disturbances in male patients with obstructive sleep apnea \n                    Am J Med  \n                    2004; \n                    117\n                    : 118-21.","journal-title":"Am J Med"},{"key":"refR41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00547-005-2032-z","volume":"00","author":"Al-Shaer M","year":"2005","unstructured":"Al-Shaer M,  Shammas N, Lemke J, et al. \n                    CPAP does not reduce high-sensitivity C-Reactive protein in patients with coronary artery disease and obstructive sleep apnea \n                    Int J Angiol  \n                    2005; \n                    00\n                    : 129-32.","journal-title":"Int J Angiol"},{"key":"refR42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/thx.2004.039164","volume":"61","author":"Lattimore JL","year":"2006","unstructured":"Lattimore JL, Wilcox I, Skilton M, Langenfeld M, Celermajer DS. \n                    Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation \n                    Thorax  \n                    2006; \n                    61\n                    : 491-5.","journal-title":"Thorax"},{"key":"refR43","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.rmed.2006.03.015","volume":"100","author":"Kitahara Y","year":"2006","unstructured":"Kitahara Y, Hattori N, Yokoyama A, Nakajima M, Kohno N. \n                    Effect of CPAP on brachial-ankle pulse wave velocity in pa-tients with OSAHS: an open-labelled study \n                    Respir Med  \n                    2006; \n                    100\n                    : 2160-9.","journal-title":"Respir Med"},{"key":"refR44","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/thx.2006.074351","volume":"62","author":"West SD","year":"2007","unstructured":"West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. \n                    Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes \n                    Thorax  \n                    2007; \n                    62\n                    : 969-74.","journal-title":"Thorax"},{"key":"refR45","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1164\/rccm.200703-500OC","volume":"176","author":"Drager LF","year":"2007","unstructured":"Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF. \n                    Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea \n                    Am J Respir Crit Care Med  \n                    2007; \n                    176\n                    : 706-12.","journal-title":"Am J Respir Crit Care Med"},{"key":"refR46","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1183\/09031936.00043306","volume":"29","author":"Coughlin SR","year":"2007","unstructured":"Coughlin SR, Mawdsley L, Mugarza JA, Wilding JP, Calverley PM. \n                    Cardiovascular and metabolic effects of CPAP in obese males with OSA \n                    Eur Respir J  \n                    2007; \n                    29\n                    : 720-.","journal-title":"Eur Respir J"},{"key":"refR47","first-page":"24","volume":"122","author":"Li C","year":"2009","unstructured":"Li C, Zhang XL, Liu H, Wang ZG, Yin KS. \n                    Association among plasma interleukin-18 levels, carotid intimamedia thickness and severity of obstructive sleep apnea \n                    Chin Med J (Engl)  \n                    2009; \n                    122\n                    : 24-9.","journal-title":"Chin Med J (Engl)"},{"key":"refR48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2174\/138161209787315729","volume":"15","author":"Athyros VG","year":"2009","unstructured":"Athyros VG, Kakafika AI, Tziomalos K, Karagiannis A, Mikhailidis DP. \n                    Pleiotropic effects of statins- clinical evidence \n                    Curr Pharm Des  \n                    2009; \n                    15\n                    : 479-89.","journal-title":"Curr Pharm Des"},{"key":"refR49","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2174\/157339910791162943","volume":"6","author":"Steiropoulos P","year":"2010","unstructured":"Steiropoulos P, Papanas N, Nena E, Maltezos E, Bouros D. \n                    Continuous positive airway pressure treatment in patients with sleep apnoea: does it really improve glucose metabolism? \n                    Curr Diabetes Rev  \n                    2010; \n                    6\n                    : 156-66.","journal-title":"Curr Diabetes Rev"},{"key":"refR50","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.sleep.2008.10.004","volume":"10","author":"Steiropoulos P","year":"2009","unstructured":"Steiropoulos P, Papanas N, Nena E, et al. \n                    Markers of glycemic control and insulin resistance in non-diabetic patients with Obstructive Sleep Apnea Hypopnea Syndrome: does adherence to CPAP treatment improve glycemic control? \n                    Sleep Med  \n                    2009; \n                    10\n                    : 887-91.","journal-title":"Sleep Med"},{"key":"refR51","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1183\/09031936.00108109","volume":"34","author":"Steiropoulos P","year":"2009","unstructured":"Steiropoulos P, Papanas N, Maltezos E, Bouros D. \n                    Is there a metabolic effect of continuous positive airway pressure in sleep apnoea? Adherence should not be underestimated \n                    Eur Respir J  \n                    2009; \n                    34\n                    : 1209-0.","journal-title":"Eur Respir J"}],"container-title":["The Open Cardiovascular Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/opencardiovascularmedicinejournal.com\/contents\/volumes\/V5\/TOCMJ-5-231\/TOCMJ-5-231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/opencardiovascularmedicinejournal.com\/contents\/volumes\/V5\/TOCMJ-5-231\/TOCMJ-5-231.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/opencardiovascularmedicinejournal.com\/contents\/volumes\/V5\/TOCMJ-5-231\/TOCMJ-5-231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T11:06:12Z","timestamp":1561633572000},"score":1,"resource":{"primary":{"URL":"https:\/\/opencardiovascularmedicinejournal.com\/VOLUME\/5\/PAGE\/231\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,26]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12,26]]}},"alternative-id":["TOCMJ-5-231"],"URL":"https:\/\/doi.org\/10.2174\/1874192401105010231","relation":{},"ISSN":["1874-1924"],"issn-type":[{"value":"1874-1924","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12,26]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2011-8-4","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-11-2","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-12-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}